Purchases and Sales Made in Q3 2022 in Myriad Genetics Inc (MYGN)
This table provides information about the institutional ownership of Myriad Genetics Inc (MYGN) during Q3 2022. The information is specifically focused on institutions that hold shares of MYRIAD GENETICS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Polar Asset Management Partners Inc.
Toronto, A6 |
SELL
|
- |
-205K- 17.36% |
$3.73M - $5.71M
|
975K
$13.4M
|
|
|
Nov 14, 2022
Q3 2022
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-222K- 31.63% |
$4.04M - $6.19M
|
480K
$6.6M
|
|
|
Nov 14, 2022
Q3 2022
|
Glenview Capital Management, LLC
New York, NY |
SELL
|
- |
-235K- 13.87% |
$4.28M - $6.56M
|
1.46M
$20.1M
|
|
|
Nov 14, 2022
Q3 2022
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-284K- 13.94% |
$5.18M - $7.93M
|
1.76M
$24.1M
|
|
|
Nov 14, 2022
Q3 2022
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-435K- 36.96% |
$7.92M - $12.1M
|
742K
$10.2M
|